COM:CSAMHEALTH
Omda
- Stock
Market Cap
100.72M
Beta: -
Volume Today
21
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 5.20K - | 936.40K 17,911.41% | 1.88M 100.94% | 950.54K 49.48% | ||
average payables | 1.33M - | 1.82M 36.81% | 1.74M 4.60% | 1.47M 15.40% | ||
average receivables | 7.09M - | 9.36M 32.02% | 8.90M 4.87% | 8.24M 7.36% | ||
book value per share | 0.19 - | 1.39 645.34% | 0.93 33.16% | 0.14 84.91% | ||
capex per share | -0.56 - | -0.15 72.43% | -0.15 0.41% | -0.20 31.57% | ||
capex to depreciation | -1.86 - | -0.67 63.77% | -0.34 49.25% | -0.47 37.59% | 0.69 247.08% | |
capex to operating cash flow | -1.63 - | -0.95 41.78% | 18.28 2,022.26% | 1.86 89.82% | -28.27 1,619.59% | |
capex to revenue | -0.50 - | -0.12 75.91% | -0.09 27.79% | -0.11 30.80% | -0.11 3.57% | |
cash per share | 0.12 - | 1.70 1,278.64% | 1.52 10.86% | 0.96 37.00% | ||
days of inventory on hand | 0.08 - | 0.10 30.29% | 19.50 18,888.03% | 18.27 6.35% | 0.08 99.58% | |
days payables outstanding | 24.15 - | 22.67 6.14% | 24.09 6.28% | 11.29 53.12% | 29.63 162.34% | |
days sales outstanding | 100.13 - | 105.90 5.77% | 107.11 1.14% | 66.62 37.80% | 86.68 30.11% | |
debt to assets | 0.46 - | 0.43 6.22% | 0.60 40.14% | 0.76 26.60% | 0.62 19.23% | |
debt to equity | 4.64 - | 1.14 75.33% | 3.00 162.21% | 18.38 512.39% | 4.54 75.32% | |
dividend yield | 0.04 - | 0.09 122.47% | ||||
earnings yield | -0.04 - | -0.01 73.87% | -0.10 807.13% | -0.13 36.85% | ||
enterprise value | 116.20M - | 98.35M 15.36% | 124.86M 26.96% | 131.38M 5.23% | 34.98M 73.38% | |
enterprise value over ebitda | 29.79 - | 14.67 50.76% | 27.13 84.95% | 91.33 236.63% | 5.78 93.67% | |
ev to operating cash flow | 16.25 - | 29.05 78.74% | -703.97 2,523.25% | -57.29 91.86% | 222.25 487.94% | |
ev to sales | 4.97 - | 3.68 26.06% | 3.35 8.97% | 3.50 4.61% | 0.86 75.38% | |
free cash flow per share | -0.22 - | 0.01 103.65% | -0.16 2,164.95% | -0.31 91.80% | ||
free cash flow yield | -0.04 - | 0.00 103.65% | -0.03 2,164.95% | -0.06 91.80% | ||
graham net net | -1.34 - | -0.33 75.67% | -1.74 431.91% | -1.99 14.11% | ||
graham number | 0.91 - | 1.27 39.55% | 3.12 146.24% | 1.42 54.56% | ||
income quality | -1.73 - | -3.14 81.23% | 0.02 100.58% | 0.17 844.88% | 0.02 91.01% | |
intangibles to total assets | 5.94 - | 3.21 45.99% | 4.25 32.51% | 5.26 23.68% | 0.08 98.40% | |
interest coverage | -1.08 - | 0.65 160.09% | -1.53 335.72% | -1.91 25.41% | 2.67 239.54% | |
interest debt per share | 0.97 - | 1.73 78.59% | 2.94 69.62% | 2.76 5.94% | ||
inventory turnover | 4.63K - | 3.55K 23.25% | 18.71 99.47% | 19.98 6.79% | 4.73K 23,548.16% | |
invested capital | 4.64 - | 1.14 75.33% | 3.00 162.21% | 18.38 512.39% | 4.54 75.32% | |
market cap | 100.72M - | 100.72M 0% | 101.02M 0.30% | 101.02M 0% | ||
net current asset value | -26.51M - | -4.90M 81.53% | -32.83M 570.28% | -38.99M 18.77% | -44.22M 13.41% | |
net debt to ebitda | 3.97 - | -0.35 108.91% | 5.18 1,565.16% | 21.11 307.47% | 5.78 72.61% | |
net income per share | -0.20 - | -0.05 73.87% | -0.47 807.13% | -0.64 36.85% | ||
operating cash flow per share | 0.34 - | 0.16 52.65% | -0.01 105.22% | -0.11 1,193.04% | ||
payables turnover | 15.11 - | 16.10 6.54% | 15.15 5.91% | 32.32 113.33% | 12.32 61.88% | |
receivables turnover | 3.65 - | 3.45 5.46% | 3.41 1.13% | 5.48 60.78% | 4.21 23.14% | |
research and ddevelopement to revenue | -0.01 - | |||||
return on tangible assets | 0.02 - | 0.01 70.19% | 0.03 392.68% | 0.04 43.20% | 0.15 230.12% | |
revenue per share | 1.12 - | 1.28 14.46% | 1.78 39.05% | 1.79 0.59% | ||
roe | -1.06 - | -0.04 96.49% | -0.50 1,257.18% | -4.57 807.13% | 0.99 121.68% | |
roic | -0.11 - | 0.04 134.01% | -0.06 270.23% | -0.13 112.72% | 0.22 270.09% | |
sales general and administrative to revenue | 0.16 - | 0.08 53.56% | 0.12 51.53% | 0.13 8.82% | ||
shareholders equity per share | 0.19 - | 1.39 645.34% | 0.93 33.16% | 0.14 84.91% | ||
stock based compensation to revenue | ||||||
tangible asset value | -230.27M - | -218.98M 4.90% | -392.74M 79.35% | -369.08M 6.03% | 3.93M 101.07% | |
tangible book value per share | -6.72 - | -6.85 1.81% | -14.84 116.70% | -14.30 3.64% | ||
working capital | -7.19M - | 28.31M 493.57% | 26.82M 5.25% | 14.11M 47.39% | 6.07M 57.01% |
All numbers in (except ratios and percentages)